Evidence map›Paper›PMID 36237434›Full record

ArticleFrontiers in cellular and infection microbiology2022

Curcumin affects function of Hsp90 and drug efflux pump of

Yean Sheng Lee, Xinyue Chen, Tria Widiasih Widiyanto, Kanami Orihara, Hiroyuki Shibata, Susumu Kajiwara

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Efficacy of Curcumin-Mediated Antimicrobial Photodynamic Therapy onInternational journal of molecular sciences · 2024
    Pooled it
  2. Identification of efflux inhibitors through a drug repurposing strategy inFrontiers in cellular and infection microbiology · 2026
    Article
  3. Article
  4. HSF1 Activation Mechanisms, Disease Roles, and Small Molecule Therapeutics.International journal of biological sciences · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yean Sheng LeeSchool of Life Science and Technology, Tokyo Institute of Technology, Yokohama, Japan.
Xinyue ChenSchool of Life Science and Technology, Tokyo Institute of Technology, Yokohama, Japan.
Tria Widiasih WidiyantoSchool of Life Science and Technology, Tokyo Institute of Technology, Yokohama, Japan.
Kanami OriharaSchool of Life Science and Technology, Tokyo Institute of Technology, Yokohama, Japan.
Hiroyuki ShibataGraduate School of Medicine, Akita University, Akita, Japan.
Susumu KajiwaraSchool of Life Science and Technology, Tokyo Institute of Technology, Yokohama, Japan.
Tokyo Institute of Technology · JPAkita University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biological ProductsCurcuminAntifungal AgentsCandida albicansDoxycyclineDrug Resistance, FungalFungal ProteinsHSP90 Heat-Shock ProteinsHumansMicrobial Sensitivity TestsTranscription FactorsAntifungal AgentsBiological ProductsCurcuminDoxycyclineFungal ProteinsHSP90 Heat-Shock ProteinsTranscription Factorsantifugal activityCDR1Hsp90pathogenic funguspost-transcripional control

Identifiers

PMID36237434
PMCPMC9551236
OpenAlexW4297425257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.